Genetic Technologies Limited (GENE)
NASDAQ: GENE · IEX Real-Time Price · USD
2.320
-0.120 (-4.92%)
Apr 19, 2024, 4:00 PM EDT - Market closed
Genetic Technologies Income Statement
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
| Year | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 - 2003 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 8.69 | 6.79 | 0.12 | 0.01 | 0.03 | 0.19 | 0.52 | 1.13 | 3.04 | 5.43 | Upgrade
|
| Revenue Growth (YoY) | 27.83% | 5536.33% | 1122.16% | -61.23% | -86.56% | -63.50% | -53.92% | -62.98% | -44.01% | -33.50% | Upgrade
|
| Cost of Revenue | 4.34 | 3.01 | 0.17 | 0.1 | 0.28 | 0.3 | 0.49 | 0.74 | 0.89 | 1.84 | Upgrade
|
| Gross Profit | 4.35 | 3.78 | -0.05 | -0.09 | -0.25 | -0.11 | 0.03 | 0.38 | 2.15 | 3.59 | Upgrade
|
| Selling, General & Admin | 9.16 | 7.91 | 4.3 | 2.35 | 4.41 | 4.08 | 5.83 | 6.62 | 8.73 | 9.42 | Upgrade
|
| Research & Development | 2.64 | 2.54 | 2.63 | 2.9 | 2.36 | 2.21 | 2.37 | 2.58 | 2.85 | 3.3 | Upgrade
|
| Other Operating Expenses | 6.49 | 3.3 | 1.7 | 2.03 | 0 | 0 | 0.54 | 0.1 | 0.44 | 1.08 | Upgrade
|
| Operating Expenses | 18.29 | 13.75 | 8.63 | 7.27 | 6.77 | 6.29 | 8.74 | 9.3 | 12.01 | 13.8 | Upgrade
|
| Operating Income | -13.94 | -9.97 | -8.68 | -7.36 | -7.02 | -6.4 | -8.72 | -8.92 | -9.87 | -10.21 | Upgrade
|
| Interest Expense / Income | 0.03 | 0.02 | 0.02 | 0.07 | 0.02 | 0.03 | 0.03 | 0.03 | 0.26 | 0.74 | Upgrade
|
| Other Expense / Income | -2.06 | -2.82 | -1.62 | -1.14 | -0.61 | -0.97 | -0.34 | -0.49 | -1.32 | -0.83 | Upgrade
|
| Pretax Income | -11.91 | -7.16 | -7.08 | -6.29 | -6.43 | -5.46 | -8.4 | -8.46 | -8.81 | -10.13 | Upgrade
|
| Income Tax | -0.16 | -0.03 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | Upgrade
|
| Net Income | -11.75 | -7.13 | -7.08 | -6.29 | -6.43 | -5.46 | -8.4 | -8.46 | -8.81 | -10.13 | Upgrade
|
| Shares Outstanding (Basic) | 101 | 92 | 85 | 42 | 26 | 24 | 21 | 17 | 11 | 6 | Upgrade
|
| Shares Outstanding (Diluted) | 101 | 92 | 85 | 42 | 26 | 24 | 21 | 17 | 11 | 6 | Upgrade
|
| Shares Change | 9.95% | 7.91% | 105.63% | 57.66% | 8.22% | 14.78% | 23.70% | 59.88% | 86.72% | 21.71% | Upgrade
|
| EPS (Basic) | -7.20 | -48.00 | -48.00 | -90.00 | -144.00 | -132.00 | -240.00 | -294.00 | -492.00 | -1056.00 | Upgrade
|
| EPS (Diluted) | -7.20 | -48.00 | -48.00 | -90.00 | -144.00 | -132.00 | -240.00 | -294.00 | -492.00 | -1056.00 | Upgrade
|
| Free Cash Flow | -9.74 | -5.72 | -7.04 | -5.71 | -6.12 | -5.64 | -7.03 | -8.02 | -9.83 | -11.04 | Upgrade
|
| Free Cash Flow Per Share | -57.65 | -37.24 | -49.47 | -82.50 | -139.41 | -138.93 | -198.94 | -280.66 | -549.61 | -1152.36 | Upgrade
|
| Gross Margin | 50.09% | 55.65% | -41.39% | -928.32% | -985.78% | -58.56% | 5.03% | 33.96% | 70.67% | 66.14% | Upgrade
|
| Operating Margin | -160.45% | -146.69% | -7203.11% | -74648.82% | -27581.59% | -3383.58% | -1680.97% | -792.98% | -324.66% | -188.13% | Upgrade
|
| Profit Margin | -135.28% | -104.95% | -5870.91% | -63815.64% | -25253.91% | -2887.06% | -1620.78% | -751.82% | -289.90% | -186.53% | Upgrade
|
| Free Cash Flow Margin | -112.14% | -84.23% | -5843.55% | -57919.69% | -24066.54% | -2979.55% | -1356.70% | -713.09% | -323.36% | -203.29% | Upgrade
|
| EBITDA | -11.88 | -7.15 | -7.06 | -6.22 | -6.41 | -5.44 | -8.37 | -8.43 | -8.55 | -9.38 | Upgrade
|
| EBITDA Margin | -136.77% | -105.20% | -5857.36% | -63084.90% | -25175.18% | -2871.82% | -1614.61% | -749.25% | -281.19% | -172.82% | Upgrade
|
| EBIT | -11.88 | -7.15 | -7.06 | -6.22 | -6.41 | -5.44 | -8.37 | -8.43 | -8.55 | -9.38 | Upgrade
|
| EBIT Margin | -136.77% | -105.20% | -5857.36% | -63084.90% | -25175.18% | -2871.82% | -1614.61% | -749.25% | -281.19% | -172.82% | Upgrade
|
Source: Financials are provided by Nasdaq Data Link and sourced from audited reports submitted to the Securities and Exchange Commission (SEC).